ALT
Income statement / Annual
Last year (2024), Altimmune, Inc.'s total revenue was $20.00 K,
a decrease of 95.31% from the previous year.
In 2024, Altimmune, Inc.'s net income was -$95.06 M.
See Altimmune, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$20.00 K |
$426.00 K |
-$68.00 K |
$4.41 M |
$8.19 M |
$5.80 M |
$10.33 M |
$41.50 K |
$5.23 M |
$10.64 M |
| Cost of Revenue |
$0.00
|
$477.00 K
|
$68.00 K
|
$551.30 K
|
$0.00
|
$17.07 M
|
$18.46 M
|
$18.41 M
|
$7.22 M
|
$5.06 M
|
| Gross Profit |
$20.00 K
|
-$51.00 K
|
-$568.00 K
|
$3.86 M
|
-$25.32 M
|
-$11.26 M
|
-$8.13 M
|
-$18.36 M
|
-$1.99 M
|
$5.58 M
|
| Gross Profit Ratio |
1
|
-0.12
|
8.35
|
0.88
|
-3.09
|
-1.94
|
-0.79
|
-442.49
|
-0.38
|
0.52
|
| Research and Development Expenses |
$82.23 M
|
$65.80 M
|
$70.54 M
|
$74.54 M
|
$49.77 M
|
$17.77 M
|
$18.46 M
|
$18.41 M
|
$4.84 M
|
$5.13 M
|
| General & Administrative Expenses |
$20.97 M
|
$18.14 M
|
$17.13 M
|
$15.41 M
|
$13.21 M
|
$8.50 M
|
$9.77 M
|
$8.46 M
|
$11.52 M
|
$6.22 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$282.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$20.97 M
|
$18.14 M
|
$17.13 M
|
$15.41 M
|
$13.21 M
|
$8.50 M
|
$9.77 M
|
$8.46 M
|
$11.52 M
|
$6.22 M
|
| Other Expenses |
$0.00
|
$12.42 M
|
-$32.00 K
|
$11.37 M
|
$0.00
|
$15.14 K
|
$277.89 K
|
$5.67 K
|
$7.85 K
|
$8.14 K
|
| Operating Expenses |
$103.19 M
|
$96.36 M
|
$87.67 M
|
$89.95 M
|
$62.98 M
|
$26.27 M
|
$28.22 M
|
$16.17 M
|
$16.49 M
|
$11.50 M
|
| Cost And Expenses |
$103.19 M
|
$96.36 M
|
$87.67 M
|
$101.32 M
|
$62.98 M
|
$26.27 M
|
$28.22 M
|
$16.17 M
|
$16.49 M
|
$11.50 M
|
| Interest Income |
$8.07 M
|
$7.35 M
|
$2.87 M
|
$203.00 K
|
$322.51 K
|
$843.41 K
|
$226.60 K
|
$47.58 K
|
$1.05 K
|
$0.00
|
| Interest Expense |
$9.00 K
|
$35.00 K
|
$8.00 K
|
$5.00 K
|
$9.42 K
|
$2.24 K
|
$297.09 K
|
$162.14 K
|
$38.50 K
|
$54.58 K
|
| Depreciation & Amortization |
$238.00 K
|
$477.00 K
|
$500.00 K
|
$551.00 K
|
$428.88 K
|
$387.32 K
|
$302.37 K
|
$139.02 K
|
$135.35 K
|
$141.60 K
|
| EBITDA |
-$94.81 M |
-$87.94 M |
-$84.40 M |
-$96.53 M |
-$54.15 M |
-$20.19 M |
-$44.72 M |
-$51.76 M |
-$10.91 M |
-$3.18 M |
| EBITDA Ratio |
-4740.6
|
-206.42
|
1241.21
|
-21.89
|
-6.62
|
-3.48
|
-4.33
|
-1247.2
|
-2.09
|
-0.3
|
| Operating Income Ratio |
-5158.6
|
-225.19
|
1290.29
|
-21.98
|
-6.69
|
-3.7
|
-4.15
|
-1254.01
|
-2.15
|
-0.32
|
| Total Other Income/Expenses Net |
$8.11 M
|
$7.48 M
|
$2.83 M
|
-$176.82 K
|
$337.24 K
|
$886.30 K
|
-$2.49 M
|
-$18.51 K
|
$4.85 K
|
$3.21 M
|
| Income Before Tax |
-$95.06 M
|
-$88.45 M
|
-$84.91 M
|
-$97.09 M
|
-$54.46 M
|
-$20.58 M
|
-$45.32 M
|
-$52.06 M
|
$205.02 M
|
-$3.38 M
|
| Income Before Tax Ratio |
-4752.95
|
-207.62
|
1248.68
|
-22.02
|
-6.65
|
-3.55
|
-4.39
|
-1254.46
|
39.2
|
-0.32
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$197.00 K
|
-$919.51 K
|
-$5.42 M
|
-$58.50 K
|
-$6.15 M
|
-$5.64 M
|
$11.17 M
|
$61.75 K
|
| Net Income |
-$95.06 M
|
-$88.45 M
|
-$84.71 M
|
-$97.09 M
|
-$49.04 M
|
-$20.52 M
|
-$39.17 M
|
-$46.43 M
|
$193.85 M
|
-$3.44 M
|
| Net Income Ratio |
-4752.95
|
-207.62
|
1245.78
|
-22.02
|
-5.99
|
-3.54
|
-3.79
|
-1118.6
|
37.06
|
-0.32
|
| EPS |
-1.34 |
-1.66 |
-1.81 |
-2.35 |
-1.91 |
-1.56 |
-13.98 |
-108.77 |
-49.8 |
-16.13 |
| EPS Diluted |
-1.34 |
-1.66 |
-1.81 |
-2.35 |
-1.91 |
-1.56 |
-13.98 |
-108.77 |
-49.8 |
-16.13 |
| Weighted Average Shares Out |
$71.00 M
|
$53.25 M
|
$46.93 M
|
$41.28 M
|
$25.64 M
|
$13.12 M
|
$2.80 M
|
$426.83 K
|
$230.38 K
|
$213.28 K
|
| Weighted Average Shares Out Diluted |
$71.00 M
|
$53.25 M
|
$46.93 M
|
$41.28 M
|
$25.64 M
|
$13.12 M
|
$2.80 M
|
$426.83 K
|
$230.38 K
|
$213.28 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
